Glen R. Anderson - Net Worth and Insider Trading

Glen R. Anderson Net Worth

The estimated net worth of Glen R. Anderson is at least $2 Million dollars as of 2024-05-02. Glen R. Anderson is the 10% Owner of Indaptus Therapeutics Inc and owns about 1,190,400 shares of Indaptus Therapeutics Inc (INDP) stock worth over $2 Million. Details can be seen in Glen R. Anderson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Glen R. Anderson has not made any transactions after 2023-08-14 and currently still holds the listed stock(s).

Transaction Summary of Glen R. Anderson

To

Glen R. Anderson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glen R. Anderson owns 1 companies in total, including Indaptus Therapeutics Inc (INDP) .

Click here to see the complete history of Glen R. Anderson’s form 4 insider trades.

Insider Ownership Summary of Glen R. Anderson

Ticker Comapny Transaction Date Type of Owner
INDP Indaptus Therapeutics Inc 2023-08-14 10 percent owner

Glen R. Anderson Latest Holdings Summary

Glen R. Anderson currently owns a total of 1 stock. Glen R. Anderson owns 1,190,400 shares of Indaptus Therapeutics Inc (INDP) as of August 14, 2023, with a value of $2 Million.

Latest Holdings of Glen R. Anderson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INDP Indaptus Therapeutics Inc 2023-08-14 1,190,400 2.01 2,386,752

Holding Weightings of Glen R. Anderson


Glen R. Anderson Form 4 Trading Tracker

According to the SEC Form 4 filings, Glen R. Anderson has made a total of 1 transactions in Indaptus Therapeutics Inc (INDP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Indaptus Therapeutics Inc is the acquisition of 103,352 shares on August 14, 2023, which cost Glen R. Anderson around $216,006.

Insider Trading History of Glen R. Anderson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Glen R. Anderson Trading Performance

GuruFocus tracks the stock performance after each of Glen R. Anderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glen R. Anderson is -8.47%. GuruFocus also compares Glen R. Anderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glen R. Anderson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Glen R. Anderson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Glen R. Anderson

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 27.02
Relative Return to S&P 500(%) 26.68

Glen R. Anderson Ownership Network

Ownership Network List of Glen R. Anderson

No Data

Ownership Network Relation of Glen R. Anderson


Glen R. Anderson Owned Company Details

What does Indaptus Therapeutics Inc do?

Who are the key executives at Indaptus Therapeutics Inc?

Glen R. Anderson is the 10 percent owner of Indaptus Therapeutics Inc. Other key executives at Indaptus Therapeutics Inc include Chief Medical Officer Roger J. Waltzman , Chief Medical Officer Boyan Vesselinov Litchev , and director & Chief Executive Officer Jeffrey A Meckler .

Indaptus Therapeutics Inc (INDP) Insider Trades Summary

Over the past 18 months, Glen R. Anderson made 1 insider transaction in Indaptus Therapeutics Inc (INDP) with a net purchase of 103,352. Other recent insider transactions involving Indaptus Therapeutics Inc (INDP) include a net purchase of 10,000 shares made by Jeffrey A Meckler , a net purchase of 1,150 shares made by Boyan Vesselinov Litchev ,

In summary, during the past 3 months, insiders sold 0 shares of Indaptus Therapeutics Inc (INDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Indaptus Therapeutics Inc (INDP) were sold and 114,502 shares were bought by its insiders, resulting in a net purchase of 114,502 shares.

Indaptus Therapeutics Inc (INDP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Indaptus Therapeutics Inc Insider Transactions

No Available Data

Glen R. Anderson Mailing Address

Above is the net worth, insider trading, and ownership report for Glen R. Anderson. You might contact Glen R. Anderson via mailing address: 3274 Ross Road, Palo Alto Ca 94303.

Discussions on Glen R. Anderson

No discussions yet.